Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Ridgepost Capital (PX) Gains from Sales and Divestitures (2022 - 2025)

Ridgepost Capital's Gains from Sales and Divestitures history spans 4 years, with the latest figure at $720237.0 for Q1 2025.

  • For Q1 2025, Gains from Sales and Divestitures rose 16.43% year-over-year to $720237.0; the TTM value through Mar 2025 reached $720237.0, up 16.43%, while the annual FY2024 figure was $1.4 million, 4211.65% up from the prior year.
  • Gains from Sales and Divestitures for Q1 2025 was $720237.0 at Ridgepost Capital, down from $1.4 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.4 million in Q4 2024 and bottomed at $32722.0 in Q3 2024.
  • The 4-year median for Gains from Sales and Divestitures is $669430.0 (2024), against an average of $604364.7.
  • The largest YoY upside for Gains from Sales and Divestitures was 4211.65% in 2024 against a maximum downside of 96.26% in 2024.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $405419.0 in 2022, then plummeted by 91.77% to $33346.0 in 2023, then surged by 4211.65% to $1.4 million in 2024, then plummeted by 49.91% to $720237.0 in 2025.
  • Per Business Quant, the three most recent readings for PX's Gains from Sales and Divestitures are $720237.0 (Q1 2025), $1.4 million (Q4 2024), and $32722.0 (Q3 2024).